In conclusion, we suggest DOT1L to be critical for regulation of EMT-induced tumourinitiation and progression in breast cancer as an important epigenetic modifier ofEMT-TFs by collaborating with the c-Myc-p300 complex. The gene discussed is MYC; the disease is breast carcinoma.